Skip to main content
. 2016 Nov 7;7(49):81698–81714. doi: 10.18632/oncotarget.13173

Figure 7. Dual-quantification of MBD3 and 5hmC exerts a promising prognostic power for GBM patients.

Figure 7

6 GBM patients with correlated MBD3 and 5hmC content were followed up after surgery. A. IHC staining for MBD3 protein and 5hmC. (Scale bars: 100 μm) B. qRT-PCR for MBD3 mRNA. C. Dot blot for 5hmC. D. Survival times of the patients. PFS: progression-free survival; OS: overall survival.